Editor's Corner
Human Vaccines & Immunotherapeutics
Downloads and Tools
Volume 7, Issue 10 October 2011
Page 994
http://dx.doi.org/10.4161/hv.7.10.18260
Authors: Ronald W. Ellis
View affiliations Hide affiliations
- Ronald W. Ellis
-
Corresponding author: rellis@landesbioscience.com
Editor-in-Chief, Human Vaccines; Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel
Abstract:
We are very pleased to broaden the scope and accordingly the name of our journal to Human Vaccines & Immunotherapeutics as of January. This broadening is a natural outgrowth of the evolution of technologies and approaches in our field, and acknowledges the increasing confluence and synergies between the fields of vaccines and immunotherapeutics.
Preview: